Clinical Trial Update: SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

View source ↗

Summary

Abbott Medical Devices reports completion and posting of results for the SJ4 Post Approval Study in patients receiving implantable cardioverter-defibrillators (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sudden Cardiac Death
• Tachyarrhythmias

Drugs mentioned

• Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
• Implantable cardioverter-defibrillator (ICD) (implantable cardioverter-defibrillator)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Tachyarrhythmias, Sudden Cardiac Death | Status: COMPLETED | Results posted: 2017-08-14